The new, extremely effective Direct acting Antivirals (DAA) have been available and subsidised in Australia since earlier this year. The Kirby Institute is currently recruiting for a study called CEASE which has been designed to eliminate hepatitis C amongst people living with HIV in Australia. People with HIV/hepatitis C co-infection in New South Wales, Queensland, Victoria and South Australia are invited to enrol by contacting Arlen Wilcox, the Project Coordinator on (02) 9385 9970.